Amphotericin-B-mediated reactivation of latent HIV-1 infection

Virology

Volumn 331, Issue 1, 2005, Pages 106-116

  Jones, J ^a   Kosloff, B R ^b   Benveniste, E N ^b   Shaw, G M ^a,c   Kutsch, O ^a,d  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^d Heerskink School of Medicine   (United States)

Author keywords

Amphotericin B; HIV 1; J89GFP; Latency; Reactivation; Reporter cell lines; THP89GFP

Indexed keywords

AMPHOTERICIN B;

ANTIGEN PRESENTING CELL; ARTICLE; CELL CULTURE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MACROPHAGE; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS LATENCY; VIRUS REACTIVATION;

AMILORIDE; AMPHOTERICIN B; ANTIFUNGAL AGENTS; BUTADIENES; CELL LINE; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION; HIV-1; HUMANS; NITRILES; SODIUM-HYDROGEN ANTIPORTER; TUMOR NECROSIS FACTOR-ALPHA; VIRUS ACTIVATION; VIRUS LATENCY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 10044257465     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virol.2004.10.013     Document Type: Article

References (74)

1. K. Andersson, and R. Sundler Signalling to translational activation of tumour necrosis factor-alpha expression in human THP-1 cells Cytokine 12 12 2000 1784 1787
2. O. Bagasra, E. Lavi, L. Bobroski, K. Khalili, J.P. Pestaner, R. Tawadros, and R.J. Pomerantz Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: identification by the combination of in situ polymerase chain reaction and immunohistochemistry AIDS 10 6 1996 573 585
3. P. Biswas, G. Poli, A.L. Kinter, J.S. Justement, S.K. Stanley, W.J. Maury, P. Bressler, J.M. Orenstein, and A.S. Fauci Interferon gamma induces the expression of human immunodeficiency virus in persistently infected promonocytic cells (U1) and redirects the production of virions to intracytoplasmic vacuoles in phorbol myristate acetate-differentiated U1 cells J. Exp. Med. 176 3 1992 739 750
4. + cell model of chronic infection J. Virol. 65 9 1991 4645 4653
5. + cells AIDS 5 12 1991 1453 1461
6. V.K. Chaudhary, T. Mizukami, T.R. Fuerst, D.J. FitzGerald, B. Moss, I. Pastan, and E.A. Berger Selective killing of HIV-infected cells by recombinant human CD4-Pseudomonas exotoxin hybrid protein Nature 335 6188 1988 369 372
7. J.K. Chia, and M. Pollack Amphotericin B induces tumor necrosis factor production by murine macrophages J. Infect. Dis. 159 1 1989 113 116
8. T.W. Chun, L. Carruth, D. Finzi, X. Shen, J.A. DiGiuseppe, H. Taylor, M. Hermankova, K. Chadwick, J. Margolick, T.C. Quinn, Y.H. Kuo, R. Brookmeyer, M.A. Zeiger, P. Barditch-Crovo, and R.F. Siliciano Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection Nature 387 6629 1997 183 188
9. T.W. Chun, L. Stuyver, S.B. Mizell, L.A. Ehler, J.A. Mican, M. Baseler, A.L. Lloyd, M.A. Nowak, and A.S. Fauci Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy Proc. Natl. Acad. Sci. U.S.A. 94 24 1997 13193 13197
10. T.W. Chun, D. Engel, M.M. Berrey, T. Shea, L. Corey, and A.S. Fauci Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection Proc. Natl. Acad. Sci. U.S.A. 95 15 1998 8869 8873
11. T.W. Chun, R.T. Davey Jr., D. Engel, H.C. Lane, and A.S. Fauci Re-emergence of HIV after stopping therapy Nature 401 6756 1999 874 875
12. + T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy Nat. Med. 5 6 1999 651 655
13. T.W. Chun, R.T. Davey Jr., M. Ostrowski, J. Shawn Justement, D. Engel, J.I. Mullins, and A.S. Fauci Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy Nat. Med. 6 7 2000 757 761
14. P. Clayette, M. Martin, V. Beringue, N. Dereuddre-Bosquet, K.T. Adjou, M. Seman, and D. Dormont Effects of MS-8209, an amphotericin B derivative, on tumor necrosis factor alpha synthesis and human immunodeficiency virus replication in macrophages Antimicrob. Agents Chemother. 44 2 2000 405 407
15. J.E. Clements, T. Babas, J.L. Mankowski, K. Suryanarayana, M. Piatak Jr., P.M. Tarwater, J.D. Lifson, and M.C. Zink The central nervous system as a reservoir for simian immunodeficiency virus (SIV): steady-state levels of SIV DNA in brain from acute through asymptomatic infection J. Infect. Dis. 186 7 2002 905 913
16. R.J. Coker, M. Viviani, B.G. Gazzard, B. Du Pont, H.D. Pohle, S.M. Murphy, J. Atouguia, J.L. Champalimaud, and J.R. Harris Treatment of cryptococcosis with liposomal amphotericin B (AmBisome) in 23 patients with AIDS AIDS 7 6 1993 829 835
17. S.M. Crowe, and S. Sonza HIV-1 can be recovered from a variety of cells including peripheral blood monocytes of patients receiving highly active antiretroviral therapy: a further obstacle to eradication J. Leukocyte Biol. 68 3 2000 345 350
18. S. Crowe, T. Zhu, and W.A. Muller The contribution of monocyte infection and trafficking to viral persistence, and maintenance of the viral reservoir in HIV infection J. Leukocyte Biol. 74 5 2003 635 641
19. R.T. Davey, N. Bhat, C. Yoder, T.W. Chun, J.A. Metcalf, R. Dewar, V. Natarajan, R.A. Lempicki, J.W. Adelsberger, K.D. Miller, J.A. Kovacs, M.A. Polis, R.E. Walker, J. Falloon, H. Masur, D. Gee, M. Baseler, D.S. Dimitrov, A.S. Fauci, and H.C. Lane HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression Proc. Natl. Acad. Sci. U.S.A. 96 26 1999 15109 15114
20. R. Demaimay, K.T. Adjou, V. Beringue, S. Demart, C.I. Lasmezas, J.P. Deslys, M. Seman, and D. Dormont Late treatment with polyene antibiotics can prolong the survival time of scrapie-infected animals J. Virol. 71 12 1997 9685 9689
21. R. Demaimay, R. Race, and B. Chesebro Effectiveness of polyene antibiotics in treatment of transmissible spongiform encephalopathy in transgenic mice expressing Syrian hamster PrP only in neurons J. Virol. 73 4 1999 3511 3513
22. M. Demuth, S. Czub, U. Sauer, E. Koutsilieri, P. Haaft, J. Heeney, C. Stahl-Hennig, V. ter Meulen, and S. Sopper Relationship between viral load in blood, cerebrospinal fluid, brain tissue and isolated microglia with neurological disease in macaques infected with different strains of SIV J. NeuroVirol. 6 3 2000 187 201
23. E.J. Duh, W.J. Maury, T.M. Folks, A.S. Fauci, and A.B. Rabson Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kB sites in the long terminal repeat Proc. Natl. Acad. Sci. U.S.A. 86 15 1989 5974 5978
24. M. Dybul, B. Hidalgo, T.W. Chun, M. Belson, S.A. Migueles, J.S. Justement, B. Herpin, C. Perry, C.W. Hallahan, R.T. Davey, J.A. Metcalf, M. Connors, and A.S. Fauci Pilot study of the effects of intermittent interleukin-2 on human immunodeficiency virus (HIV)-specific immune responses in patients treated during recently acquired HIV infection J. Infect. Dis. 185 1 2002 61 68
25. T.M. Folks, J. Justement, A. Kinter, C.A. Dinarello, and A.S. Fauci Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line Science 238 4828 1987 800 802
26. T.M. Folks, J. Justement, A. Kinter, S. Schnittman, J. Orenstein, G. Poli, and A.S. Fauci Characterization of a promonocyte clone chronically infected with HIV and inducible by 13-phorbol-12-myristate acetate J. Immunol. 140 4 1988 1117 1122
27. R.J. Guiloff, and S.V. Tan Central nervous system opportunistic infections in HIV disease: clinical aspects Bailliere's Clin. Neurol. 1 1 1992 103 154
28. D.H. Hamer, S. Bocklandt, L. McHugh, T.W. Chun, P.M. Blumberg, D.M. Sigano, and V.E. Marquez Rational design of drugs that induce human immunodeficiency virus replication J. Virol. 77 19 2003 10227 10236
29. J.E. Hansen, N.M. Witzke, C. Nielsen, L.R. Mathiesen, L.S. Teglbjaerg, C.M. Nielsen, and J.O. Nielsen Derivatives of amphotericin inhibit infection with human immunodeficiency virus in vitro by different modes of action Antiviral Res. 14 3 1990 149 159
30. S.M. Hsieh, C.C. Hung, M.Y. Chen, P.R. Hsueh, and S.C. Chang Efficacy and adverse effects of higher dose amphotericin B monotherapy for cryptococcal meningitis in patients with advanced HIV infection J. Microbiol. Immunol. Infect. 31 4 1998 233 239
31. T. Igarashi, C.R. Brown, Y. Endo, A. Buckler-White, R. Plishka, N. Bischofberger, V. Hirsch, and M.A. Martin Macrophage are the principal reservoir and sustain high virus loads in rhesus macaques after the depletion of CD4+T cells by a highly pathogenic simian immunodeficiency virus/HIV type 1 chimera (SHIV): Implications for HIV-1 infections of humans Proc. Natl. Acad. Sci. U.S.A. 98 2 2001 658 663
32. K. Konopka, L.S. Guo, and N. Duzgunes Anti-HIV activity of amphotericin B-cholesteryl sulfate colloidal dispersion in vitro Antiviral Res. 42 3 1999 197 209
33. Y.D. Korin, D.G. Brooks, S. Brown, A. Korotzer, and J.A. Zack Effects of prostratin on T-cell activation and human immunodeficiency virus latency J. Virol. 76 16 2002 8118 8123
34. J.A. Kovacs, H. Imamichi, S. Vogel, J.A. Metcalf, R.L. Dewar, M. Baseler, R. Stevens, J. Adelsberger, L. Lambert, R.T. Davey Jr., R.E. Walker, J. Falloon, M.A. Polis, H. Masur, and H.C. Lane Effects of intermittent interleukin-2 therapy on plasma and tissue human immunodeficiency virus levels and quasi-species expression J. Infect. Dis. 182 4 2000 1063 1069
35. J.A. Kovacs, S. Vogel, J.A. Metcalf, M. Baseler, R. Stevens, J. Adelsberger, R. Lempicki, R.L. Hengel, I. Sereti, L. Lambert, R.L. Dewar, R.T. Davey Jr., R.E. Walker, J. Falloon, M.A. Polis, H. Masur, and H.C. Lane Interleukin-2 induced immune effects in human immunodeficiency virus-infected patients receiving intermittent interleukin-2 immunotherapy Eur. J. Immunol. 31 5 2001 1351 1360
36. J. Kulkosky, D.M. Culnan, J. Roman, G. Dornadula, M. Schnell, M.R. Boyd, and R.J. Pomerantz Prostratin: activation of latent HIV-1 expression suggests a potential inductive adjuvant therapy for HAART Blood 98 10 2001 3006 3015
37. J. Kulkosky, G. Nunnari, M. Otero, S. Calarota, G. Dornadula, H. Zhang, A. Malin, J. Sullivan, Y. Xu, J. DeSimone, T. Babinchak, J. Stern, W. Cavert, A. Haase, and R.J. Pomerantz Intensification and stimulation therapy for human immunodeficiency virus type 1 reservoirs in infected persons receiving virally suppressive highly active antiretroviral therapy J. Infect. Dis. 186 10 2002 1403 1411
38. O. Kutsch, E.N. Benveniste, G.M. Shaw, and D.N. Levy Direct and quantitative single-cell analysis of human immunodeficiency virus type 1 reactivation from latency J. Virol. 76 17 2002 8776 8786
39. O. Kutsch, D.N. Levy, B.R. Kosloff, G.M. Shaw, and E.N. Benveniste CD154-CD40-induced reactivation of latent HIV-1 infection Virology 314 1 2003 261 270
40. M.A. Laughlin, S. Zeichner, D. Kolson, J.C. Alwine, T. Seshamma, R.J. Pomerantz, and F. Gonzalez-Scarano Sodium butyrate treatment of cells latently infected with HIV-1 results in the expression of unspliced viral RNA Virology 196 2 1993 496 505
41. M.A. Laughlin, G.Y. Chang, J.W. Oakes, F. Gonzalez-Scarano, and R.J. Pomerantz Sodium butyrate stimulation of HIV-1 gene expression: a novel mechanism of induction independent of NF-kB J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 9 4 1995 332 339
42. F. Lebargy, A. Branellec, L. Deforges, J. Bignon, and J.F.a. Bernaudin HIV-1 in human alveolar macrophages from infected patients is latent in vivo but replicates after in vitro stimulation Am. J. Respir. Cell Mol. Biol. 10 1 1994 72 78
43. A. Makutonina, T.G. Voss, D.R. Plymale, C.D. Fermin, C.H. Norris, S. Vigh, and R.F. Garry Human immunodeficiency virus infection of T-lymphoblastoid cells reduces intracellular pH J. Virol. 70 10 1996 7049 7055
44. F. Marty, and E. Mylonakis Antifungal use in HIV infection Expert Opin. Pharmacother. 3 2 2002 91 102
45. L. McHugh, S. Hu, B.K. Lee, K. Santora, P.E. Kennedy, E.A. Berger, I. Pastan, and D.H. Hamer Increased affinity and stability of an anti-HIV-1 envelope immunotoxin by structure-based mutagenesis J. Biol. Chem. 277 37 2002 34383 34390
46. D.S. McKinsey, M.R. Gupta, S.A. Riddler, M.R. Driks, D.L. Smith, and P.J. Kurtin Long-term amphotericin B therapy for disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome (AIDS) Ann. Intern. Med. 111 8 1989 655 659
47. M.S. Meltzer, and H.E. Gendelman Mononuclear phagocytes as targets, tissue reservoirs, and immunoregulatory cells in human immunodeficiency virus disease Curr. Top. Microbiol. Immunol. 181 1992 239 263
48. M.S. Meltzer, D.R. Skillman, P.J. Gomatos, D.C. Kalter, and H.E. Gendelman Role of mononuclear phagocytes in the pathogenesis of human immunodeficiency virus infection Annu. Rev. Immunol. 8 1990 169 194
49. J.A. Mikovits, N.C. Lohrey, R. Schulof, J. Courtless, and F.W. Ruscetti Activation of infectious virus from latent human immunodeficiency virus infection of monocytes in vivo J. Clin. Invest. 90 4 1992 1486 1491
50. J.M. Orenstein, C. Fox, and S.M. Wahl Macrophages as a source of HIV during opportunistic infections Science 276 5320 1997 1857 1861
51. T. Otake, K. Miyano, H. Mori, M. Kanai, N. Ueba, N. Kunita, and T. Kurimura In vitro anti-HIV activity of sulfated amphotericin B AIDS 3 12 1989 855
52. T. Otake, K. Miyano, H. Mori, M. Morimoto, N. Ueba, N. Kunita, H. Nakashima, and T. Kurimura Anti-HIV-1 activity of sulfated amphotericin B in vitro Antiviral Res. 16 3 1991 243 255
53. L.L. Pearson, B.E. Castle, and M.R. Kehry CD40-mediated signaling in monocytic cells: up-regulation of tumor necrosis factor receptor-associated factor mRNAs and activation of mitogen-activated protein kinase signaling pathways Int. Immunol. 13 3 2001 273 283
54. C.F. Perno, F.M. Newcomb, D.A. Davis, S. Aquaro, R.W. Humphrey, R. Calio, and R. Yarchoan Relative potency of protease inhibitors in monocytes/ macrophages acutely and chronically infected with human immunodeficiency virus J. Infect. Dis. 178 2 1998 413 422
55. O. Pleskoff, M. Seman, and M. Alizon Amphotericin B derivative blocks human immunodeficiency virus type 1 entry after CD4 binding: effect on virus-cell fusion but not on cell-cell fusion J. Virol. 69 1 1995 570 574
56. O. Pleskoff, N. Sol, H. Marrakchi, M. Serlin, M. Seman, and M. Alizon Possible role of the V3 domain of gp120 in resistance to an amphotericin B derivative (MS8209) blocking human immunodeficiency virus entry J. Virol. 70 11 1996 8247 8251
57. G. Poli, A.L. Kinter, and A.S. Fauci Interleukin 1 induces expression of the human immunodeficiency virus alone and in synergy with interleukin 6 in chronically infected U1 cells: inhibition of inductive effects by the interleukin 1 receptor antagonist Proc. Natl. Acad. Sci. U.S.A. 91 1 1994 108 112
58. D.R. Pontani, D. Sun, J.W. Brown, S.I. Shahied, O.J. Plescia, C.P. Schaffner, G. Lopez-Berestein, and P.S. Sarin Inhibition of HIV replication by liposomal encapsulated amphotericin B Antiviral Res. 11 3 1989 119 125
59. D.R. Pontani, D. Sun, J.W. Brown, S.I. Shahied, O.J. Plescia, C.P. Schaffner, G. Lopez-Berestein, and P.S. Sarin Inhibition of HIV replication by liposomal encapsulated amphotericin B Antiviral Res. 11 3 1989 119 125
60. V. Quivy, E. Adam, Y. Collette, D. Demonte, A. Chariot, C. Vanhulle, B. Berkhout, R. Castellano, Y. Launoit, A. Burny, J. Piette, V. Bours, and C. Van Lint Synergistic activation of human immunodeficiency virus type 1 promoter activity by NF-kB and inhibitors of deacetylases: potential perspectives for the development of therapeutic strategies J. Virol. 76 21 2002 11091 11103
61. E. Reyes, J. Cardona, A. Prieto, E.D. Bernstein, M. Rodriguez-Zapata, M.J. Pontes, and M. Alvarez-Mon Liposomal amphotericin B and amphotericin B-deoxycholate show different immunoregulatory effects on human peripheral blood mononuclear cells J. Infect. Dis. 181 6 2000 2003 2010
62. M.J. Root, and D.H. Hamer Targeting therapeutics to an exposed and conserved binding element of the HIV-1 fusion protein Proc. Natl. Acad. Sci. U.S.A. 100 9 2003 5016 5021
63. C.P. Schaffner, O.J. Plescia, D. Pontani, D. Sun, A. Thornton, R.C. Pandey, and P.S. Sarin Anti-viral activity of amphotericin B methyl ester: inhibition of HTLV-III replication in cell culture Biochem. Pharmacol. 35 22 1986 4110 4113
64. P.L. Sheridan, T.P. Mayall, E. Verdin, and K.A. Jones Histone acetyltransferases regulate HIV-1 enhancer activity in vitro Genes Dev. 11 24 1997 3327 3340
65. S. Sonza, and S.M. Crowe Reservoirs for HIV infection and their persistence in the face of undetectable viral load AIDS Patient Care STDs 15 10 2001 511 518
66. W.G. Spector, and G.B. Ryan New evidence for the existence of long lived macrophages Nature 221 183 1969 860
67. J. Suttles, D.M. Milhorn, R.W. Miller, J.C. Poe, L.M. Wahl, and R.D. Stout CD40 signaling of monocyte inflammatory cytokine synthesis through an ERK1/2-dependent pathway. A target of interleukin (il)-4 and il-10 anti-inflammatory action J. Biol. Chem. 274 9 1999 5835 5842
68. Y. Tokuda, M. Tsuji, M. Yamazaki, S. Kimura, S. Abe, and H. Yamaguchi Augmentation of murine tumor necrosis factor production by amphotericin B in vitro and in vivo Antimicrob. Agents Chemother. 37 10 1993 2228 2230
69. S.E. Tong-Starkesen, P.A. Luciw, and B.M. Peterlin Signaling through T lymphocyte surface proteins, TCR/CD3 and CD28, activates the HIV-1 long terminal repeat J. Immunol. 142 2 1989 702 707
70. C. Van Lint, S. Emiliani, M. Ott, and E. Verdin Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation EMBO J. 15 5 1996 1112 1120
71. T.G. Voss, C.D. Fermin, J.A. Levy, S. Vigh, B. Choi, and R.F. Garry Alteration of intracellular potassium and sodium concentrations correlates with induction of cytopathic effects by human immunodeficiency virus J. Virol. 70 8 1996 5447 5454
72. T.G. Voss, P.J. Gatti, C.D. Fermin, and R.F. Garry Reduction of human immunodeficiency virus production and cytopathic effects by inhibitors of the Na+/K+/2Cl-cotransporter Virology 219 1 1996 291 294
73. J.K. Wong, M. Hezareh, H.F. Gunthard, D.V. Havlir, C.C. Ignacio, C.A. Spina, and D.D. Richman Recovery of replication-competent HIV despite prolonged suppression of plasma viremia Science 278 5341 1997 1291 1295
74. L. Zhang, C. Chung, B.S. Hu, T. He, Y. Guo, A.J. Kim, E. Skulsky, X. Jin, A. Hurley, B. Ramratnam, M. Markowitz, and D.D. Ho Genetic characterization of rebounding HIV-1 after cessation of highly active antiretroviral therapy J. Clin. Invest. 106 7 2000 839 845